AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria by mcwebmaster | Dec 19, 2017
CARB-X Funding Award to Advance Development of LpxC Inhibitor Antibiotic to Fight Drug Resistant by mcwebmaster | Dec 19, 2017
Leveraging global surveillance data to develop rapid diagnostics: MSD & OpGen’s Collaboration by mcwebmaster | Dec 19, 2017